The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia throughinhibiting migration and enhancing cell loss of vascular smooth muscle cells

Citation
N. Negoro et al., The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia throughinhibiting migration and enhancing cell loss of vascular smooth muscle cells, BIOC BIOP R, 262(1), 1999, pp. 211-215
Citations number
28
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
262
Issue
1
Year of publication
1999
Pages
211 - 215
Database
ISI
SICI code
0006-291X(19990819)262:1<211:TKIF(R>2.0.ZU;2-A
Abstract
Smooth muscle cell (SMC) migration plays an important role in restenosis af ter angioplasty, Myosin phosphorylation is necessary for cell migration. Fa sudil is an inhibitor of protein kinases, including myosin light chain kina se and Rho associated kinase, thereby inhibiting myosin phosphorylation, an d it has been clinically used to prevent vasospasm following subarachnoid h emorrage, Based on these findings, we examined the antimigrative action of fasudil. In SMC (SM-3), fasudil (1-100 mu M) inhibited SMC migration in a d ose-dependent man ner (p < 0,001), Fasudil suppressed actin stress fiber fo rmation dose dependently. In rabbit carotid artery, fasudil (10 mg/kg/day) markedly reduced intimal hyperplasia 14 days following balloon injury. Cell kinetic study showed that fasudil did not affect proliferation but enhance d cell loss in the media after injury. We concluded that fasudil reduced ne ointimal formation after balloon injury through both inhibiting migration a nd enhancing cell loss of medial SMC. (C) 1999 Academic Press.